| Gallbladder and Bile Duct Disorders | Lifetime | 61 | JP 7 | 99.61 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 69 | JP 13 | 99.56 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 219 | JP 22 | 99.32 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 235 | JP 38 | 99.11 |
| Pediatric Hepatobiliary Diseases and Treatments | Lifetime | 287 | JP 38 | 98.32 |
| Gastric Cancer Management and Outcomes | Lifetime | 772 | JP 157 | 98.48 |
| Cancer Research and Treatments | Lifetime | 500 | JP 36 | 97.41 |
| Colorectal Cancer Treatments and Studies | Lifetime | 663 | JP 56 | 98.07 |
| Colorectal Cancer Surgical Treatments | Lifetime | 574 | JP 55 | 97.46 |
| Metastasis and carcinoma case studies | Lifetime | 466 | JP 201 | 96.67 |
| Ferroptosis and cancer prognosis | Lifetime | 518 | JP 12 | 94.77 |
| Cancer Diagnosis and Treatment | Lifetime | 866 | JP 49 | 96.15 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 886 | JP 257 | 95.94 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 478 | JP 89 | 92.53 |
| Biliary and Gastrointestinal Fistulas | Lifetime | 469 | JP 53 | 93.73 |
| Modular Robots and Swarm Intelligence | Lifetime | 833 | JP 86 | 93.52 |
| Enhanced Recovery After Surgery | Lifetime | 704 | JP 31 | 89.66 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 53 | JP 3 | 99.28 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 32 | JP 4 | 99.16 |
| Gallbladder and Bile Duct Disorders | 2021-2025 | 36 | JP 3 | 98.91 |
| Cancer Genomics and Diagnostics | 2021-2025 | 665 | JP 20 | 95.92 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 565 | JP 109 | 95.78 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 349 | JP 46 | 96.14 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 234 | JP 9 | 94.89 |
| Ferroptosis and cancer prognosis | 2021-2025 | 467 | JP 6 | 93.89 |
| Colorectal Cancer Surgical Treatments | 2021-2025 | 507 | JP 71 | 92.76 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 542 | JP 56 | 93.68 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 459 | JP 25 | 89.74 |
| Inflammatory Biomarkers in Disease Prognosis | 2021-2025 | 278 | JP 38 | 86.62 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 615 | JP 60 | 90.31 |
| Metastasis and carcinoma case studies | 2021-2025 | 306 | JP 115 | 88.84 |
| Breast Cancer Treatment Studies | 2021-2025 | 935 | JP 27 | 90.43 |
| Colorectal and Anal Carcinomas | 2021-2025 | 568 | JP 46 | 87.51 |
| Gastrointestinal Tumor Research and Treatment | 2021-2025 | 753 | JP 199 | 84.40 |
| Cancer Research and Treatments | 2021-2025 | 976 | JP 47 | 77.99 |
| Enhanced Recovery After Surgery | 2021-2025 | 628 | JP 21 | 71.94 |
| Biliary and Gastrointestinal Fistulas | 2021-2025 | 767 | JP 123 | 58.21 |
| Stoma care and complications | 2021-2025 | 835 | JP 55 | 50.65 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 728 | JP 234 | 46.65 |